Eltoprazine: Phase IIb started

Amarantus began a double-blind, placebo-controlled, 4-way crossover, international Phase IIb trial to evaluate 2.5, 5 and 7.5 mg oral eltoprazine twice daily for 3 weeks in about 60 patients. Amarantu...